Showing results (801-810 of 847) with videos related to

Sort By:
Pageof 85
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Risk of Cardiovascular Ischemic Events After Surgical Castration and Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer: A Nationwide Cohort StudyDong-Yi Chen, Lai-Chu See, Jia-Rou Liu, et al.
Journal of Pharmaceutical Sciences|May 8, 2020
Stress and Deformation of Optimally Shaped Silicon Microneedles for Transdermal Drug DeliveryHafzaliza Erny Zainal Abidin, Poh Choon Ooi, Teck Yaw Tiong, et al.
Scientific Reports|October 9, 2025
An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trialHow-Yang Tseng, Wen-Sheng Feng, Chieh-Lung Chen, et al.
The American Journal of Pathology|September 23, 2022
Deep Learning-Based Nuclear Morphometry Reveals an Independent Prognostic Factor in Mantle Cell LymphomaWen-Yu Chuang, Wei-Hsiang Yu, Yen-Chen Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2007
Regulation of p53 tetramerization and nuclear export by ARCRoger S-Y Foo, Young-Jae Nam, Marc Jason Ostreicher, et al.
Circulation|November 16, 2011
A critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced pulmonary hypertensionAri L Zaiman, Rachel Damico, Alan Thoms-Chesley, et al.
Clinical and Experimental Rheumatology|September 26, 2025
Circulating microRNAs associated with tumour necrosis factor or fibloblast-like synoviocyte predict cartilage damage in early rheumatoid arthritis treated with methotrexate plus adalimumab: a subanalysis of the MIRACLE studyYohei Hosokawa, Yusuke Yoshida, Hiroya Tamai, et al.
The Journal of Clinical Investigation|June 5, 2025
CXCL10 secreted by SPRY1-deficient epidermal keratinocytes fuels joint inflammation in psoriatic arthritis via CD14 signalingFan Xu, Ying-Zhe Cui, Xing-Yu Yang, et al.
The Lancet. Rheumatology|January 22, 2024
Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trialHiroya Tamai, Kei Ikeda, Toshiaki Miyamoto, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 2017
Family Aggregation and Heritability of ESRD in Taiwan: A Population-Based StudyHsin Hsu Wu, Chang Fu Kuo, I Jung Li, et al.
Pageof 85